×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Image search
Paste the image URL
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
Faculty of Healt... [8]
Authors
KWOK HANG FAI [3]
DAI YUNLU [2]
CHUXIA DENG [1]
ZHANG XUANJUN [1]
ZHAO QI [1]
CHEN QIANG [1]
More...
Document Type
Journal article [9]
Date Issued
2024 [2]
2023 [1]
2022 [5]
2021 [1]
Language
英語English [9]
Source Publication
Bioactive Materi... [1]
Biomedicine and ... [1]
Cancer Immunolog... [1]
Frontiers in Pha... [1]
Heliyon [1]
International Jo... [1]
More...
Indexed By
SCIE [7]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-9 of 9
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Issue Date Ascending
Issue Date Descending
Title Ascending
Title Descending
Author Ascending
Author Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Submit date Ascending
Submit date Descending
Journal Impact Factor Ascending
Journal Impact Factor Descending
Dual inhibitors of DNMT and HDAC remodels the immune microenvironment of colorectal cancer and enhances the efficacy of anti-PD-L1 therapy
Journal article
Yang ZhanBo, Chu BiZhu, Tu Yao, Li LuLu, Chen DaWei, Huang ShouHui, Huang WenJun, Fan WeiWen, Li QinYuan, Zhang CunLong, Yuan ZiGao, Huang Jumin, Leung Elaine Lai Han, Jiang Yuyang. Dual inhibitors of DNMT and HDAC remodels the immune microenvironment of colorectal cancer and enhances the efficacy of anti-PD-L1 therapy[J]. Pharmacological Research, 2024, 206, 107271.
Authors:
Yang ZhanBo
;
Chu BiZhu
;
Tu Yao
;
Li LuLu
;
Chen DaWei
; et al.
Favorite
|
TC[WOS]:
0
TC[Scopus]:
0
IF:
9.1
/
9.0
|
Submit date:2024/06/17
Dnmt
Hdac
Rig-i/mda5-mavs
Anti-pd-l1 Therapy
Tumor Immune Microenvironment
ADCY4 promotes brain metastasis in small cell lung cancer and is associated with energy metabolism
Journal article
Sun, Yidan, Chen, Yixun, Zhang, Xin, Yi, Dan, Kong, Fanming, Zhao, Linlin, Liao, Dongying, Chen, Lei, Ma, Qianqian, Wang, Ziheng. ADCY4 promotes brain metastasis in small cell lung cancer and is associated with energy metabolism[J]. Heliyon, 2024, 10(7), e28162.
Authors:
Sun, Yidan
;
Chen, Yixun
;
Zhang, Xin
;
Yi, Dan
;
Kong, Fanming
; et al.
Favorite
|
TC[WOS]:
0
TC[Scopus]:
0
IF:
3.4
/
3.9
|
Submit date:2024/05/02
Adcy4
Anti-pd1
Bms
Mfuzz
Sclc
Wgcna
A platinum@polymer-catechol nanobraker enables radio-immunotherapy for crippling melanoma tumorigenesis, angiogenesis, and radioresistance
Journal article
Li, Wenxi, Yan, Jie, Tian, Hao, Li, Bei, Wang, Guohao, Sang, Wei, Zhang, Zhan, Zhang, Xuanjun, Dai, Yunlu. A platinum@polymer-catechol nanobraker enables radio-immunotherapy for crippling melanoma tumorigenesis, angiogenesis, and radioresistance[J]. Bioactive Materials, 2023, 22, 34-46.
Authors:
Li, Wenxi
;
Yan, Jie
;
Tian, Hao
;
Li, Bei
;
Wang, Guohao
; et al.
Favorite
|
TC[WOS]:
20
TC[Scopus]:
20
IF:
18.0
/
18.2
|
Submit date:2023/05/02
Anti-angiogenesis
Anti-tumorigenesis
Melanoma Pd-1:Pd-l1 Interaction Blockade
Platinum@polymer-catechol Nanobrakers
Radio-sensitization Effect
Regulation of IFN-γ-mediated PD-L1 expression by MYC in colorectal cancer with wild-type KRAS and TP53 and its clinical implications
Journal article
Guo, Libin, Tang, Xiaoqiong, Wong, Sin Wa, Guo, Anyuan, Lin, Yao, Kwok, Hang Fai. Regulation of IFN-γ-mediated PD-L1 expression by MYC in colorectal cancer with wild-type KRAS and TP53 and its clinical implications[J]. Frontiers in Pharmacology, 2022, 13, 1022129.
Authors:
Guo, Libin
;
Tang, Xiaoqiong
;
Wong, Sin Wa
;
Guo, Anyuan
;
Lin, Yao
; et al.
Favorite
|
TC[WOS]:
3
TC[Scopus]:
3
IF:
4.4
/
5.0
|
Submit date:2023/01/30
Anti-pd-1
Ifn-γ
Kras
Myc
Pd-l1 Expression
Tp53
Ifn-gamma
Synergistic combination of targeted nano-nuclear-reactors and anti-PD-L1 nanobodies evokes persistent T cell immune activation for cancer immunotherapy
Journal article
Zhu, Lipeng, Li, Junnan, Guo, Ziang, Kwok, Hang Fai, Zhao, Qi. Synergistic combination of targeted nano-nuclear-reactors and anti-PD-L1 nanobodies evokes persistent T cell immune activation for cancer immunotherapy[J]. Journal of Nanobiotechnology, 2022, 20(1), 521.
Authors:
Zhu, Lipeng
;
Li, Junnan
;
Guo, Ziang
;
Kwok, Hang Fai
;
Zhao, Qi
Favorite
|
TC[WOS]:
10
TC[Scopus]:
12
IF:
10.6
/
11.4
|
Submit date:2023/01/30
Anti-pd-l1 Nanobody
Hypoxia Modulation
Immune-cold Tumors
Immunogenic Cell Death
Nano-nuclear-reactor
t Cell Immune Activation
ICBatlas: A Comprehensive Resource for Depicting Immune Checkpoint Blockade Therapy Characteristics from Transcriptome Profiles
Journal article
Mei Yang, Ya-Ru Miao, Gui-Yan Xie, Mei Luo, Hui Hu, Hang Fai Kwok, Jian Feng, Jian Feng. ICBatlas: A Comprehensive Resource for Depicting Immune Checkpoint Blockade Therapy Characteristics from Transcriptome Profiles[J]. Cancer Immunology Research, 2022, 10(11), 1398-1406.
Authors:
Mei Yang
;
Ya-Ru Miao
;
Gui-Yan Xie
;
Mei Luo
;
Hui Hu
; et al.
Favorite
|
TC[WOS]:
22
TC[Scopus]:
20
IF:
8.1
/
10.1
|
Submit date:2022/12/01
Anti-pd-1
Safety
Immunotherapy
Predicts
Artesunate promoted anti-tumor immunity and overcame EGFR-TKI resistance in non-small-cell lung cancer by enhancing oncogenic TAZ degradation
Journal article
Cao, Dai, Chen, Die, Xia, Jiang Nan, Wang, Wen Yan, Zhu, Guo Yuan, Chen, Li Wen, Zhang, Chuantao, Tan, Bo, Li, Hui, Li, Ying Wei. Artesunate promoted anti-tumor immunity and overcame EGFR-TKI resistance in non-small-cell lung cancer by enhancing oncogenic TAZ degradation[J]. Biomedicine and Pharmacotherapy, 2022, 155.
Authors:
Cao, Dai
;
Chen, Die
;
Xia, Jiang Nan
;
Wang, Wen Yan
;
Zhu, Guo Yuan
; et al.
Favorite
|
TC[WOS]:
10
TC[Scopus]:
10
IF:
6.9
/
6.8
|
Submit date:2023/01/31
Anti-tumor Immunity
Artesunate
Egfr-tki Resistance
Non-small-cell Lung Cancer
Pd-l1
Taz
A “three musketeers” tactic for inclining interferon-γ as a comrade-in-arm to reinforce the synergistic-tumoricidal therapy
Journal article
Li, Wenxi, Xie, Lisi, Ju, Yi, Zhang, Zhan, Li, Bei, Li, Jie, Sang, Wei, Wang, Guohao, Tian, Hao, Dai, Yunlu. A “three musketeers” tactic for inclining interferon-γ as a comrade-in-arm to reinforce the synergistic-tumoricidal therapy[J]. Nano Research, 2022, 15(4), 3458-3470.
Authors:
Li, Wenxi
;
Xie, Lisi
;
Ju, Yi
;
Zhang, Zhan
;
Li, Bei
; et al.
Favorite
|
TC[WOS]:
6
TC[Scopus]:
6
IF:
9.5
/
9.0
|
Submit date:2022/05/04
Anti-pd-l1 (Apd-l1)
Ido-1 Inhibitor (Nlg919)
Interferon-γ (Ifn-γ)
Neutralization
Positive Anti-tumor Feedback Loop
Tumoricidal
Cullin3 deficiency shapes tumor microenvironment and promotes cholangiocarcinoma in liver-specific smad4/pten mutant mice
Journal article
Zhao, Ming, Quan, Yingyao, Zeng, Jianming, Lyu, Xueying, Wang, Haitao, Lei, Josh Haipeng, Feng, Yangyang, Xu, Jun, Chen, Qiang, Sun, Heng, Xu, Xiaoling, Lu, Ligong, Deng, Chu Xia. Cullin3 deficiency shapes tumor microenvironment and promotes cholangiocarcinoma in liver-specific smad4/pten mutant mice[J]. International Journal of Biological Sciences, 2021, 17(15), 4176-4191.
Authors:
Zhao, Ming
;
Quan, Yingyao
;
Zeng, Jianming
;
Lyu, Xueying
;
Wang, Haitao
; et al.
Favorite
|
TC[WOS]:
10
TC[Scopus]:
9
IF:
8.2
/
8.3
|
Submit date:2022/05/13
Anti-pd1/pd-l1 Therapy
Cholangiocarcinoma
Exhausted t Cells
Inflammatory Cytokines
Tumor Microenvironment